Currently, the main diagnostic methods for AD include MRI and PET brain imaging, biochemical analysis of Aβ42/40, and total tau (t‐tau) and phosphorylated tau (p‐tau181) levels in the cerebrospinal fluid (CSF).4, 5, 6. The gene discussed is MAPT; the disease is Alzheimer disease.